FGFR1 and gonorrhea: While less is known about the downstream signaling pathways operative in FGFR1- and NTRK2-mutant PAs, these receptor tyrosine kinase molecules are also known to activate RAS and RAS downstream signaling and regulate growth in numerous other cancers (12–16).